Self-sampling experiences among non-attendees to cervical screening

Gynecologic Oncology

Volumn 135, Issue 3, 2014, Pages 487-494

  Virtanen, Anni ^a   Nieminen, Pekka ^b   Niironen, Meri ^a   Luostarinen, Tapio ^a   Anttila, Ahti ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b JORVI HOSPITAL   (Finland)

Author keywords

Acceptability; Cervical screening; HPV; Non attendance; Self sampling

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER SCREENING; CERVICOVAGINAL SELF-SAMPLING DEVICE; EDUCATIONAL STATUS; EMOTION; FEAR; FEMALE; HEALTH SURVEY; HUMAN; IMMIGRANT; INSECURITY; LABOR; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PERSONAL EXPERIENCE; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLING; SMOKING; UTERINE CERVIX CANCER; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DIAGNOSIS; MASS SCREENING; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; SELF CARE; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; SELF CARE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84920717080     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.09.019     Document Type: Article

References (36)

1. Wilson A, Leeming A. Cervical cytology screening: a comparison of two call systems. BMJ 1987;295:181-2.
2. Hermens RP, Hak E, Hulscher ME, Mulder J, Tacken MA, Braspenning JC, et al. Improving population-based cervical cancer screening in general practice: effects of a national strategy. Int J Qual Health Care 1999;11:193-200.
3. Jepson R, Clegg A, Forbes C, Lewis RAS, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess (Rockv) 2000;4.
4. Tseng D, Cox E, Plane M, Hla K. Efficacy of patient letter reminders on cervical cancer screening. J Gen Intern Med 2001;16:563-8.
5. Eaker S, Adami HO, Granath F, Wilander E, Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004;13:346-54.
6. Morrell S, Taylor R, Zeckendorf S, Niciak A, Wain G, Ross J. Howmuch does a reminder letter increase cervical screening among under-screenedwomen in NSW? Aust N Z J Public Health 2005;29:78-84.
7. Pritchard DA, Straton JAY, Hyndman J. Cervical screening in general practice. Aust J Public Health 2010;19:167-72.
8. Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 2011:CD002834.
9. Virtanen A, Nieminen P, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 2011;20:1960-9.
10. Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2011;128:2681-7.
11. Sanner K, Wikström I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009;101:871-4.
12. Gök M, Heideman DAM, van Kemenade FJ, de Vries ALM, Berkhof J, Rozendaal L, et al. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders. Eur J Cancer 2012;48:1799-808.
13. Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer 2011;104:915-20.
14. Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 2013;133:2681-7.
15. Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer 2011;104:248-54.
16. Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd M-L, Holtenman M, Milsom I, et al. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer 2014;134:2223-30.
17. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen 2009;16:193-8.
18. Barata PC, Mai V, Howlett R, Gagliardi AR, Stewart DE. Discussions about selfobtained samples for HPV testing as an alternative for cervical cancer prevention. J Psychosom Obstet Gynecol 2008;29:251-7.
19. Cadman L, Ashdown-Barr L, Waller J, Szarewski A. Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study. J Fam Plann Reprod Health Care 2014. http://dx.doi.org/10.1136/jfprhc-2013-100705.
20. Howard M, Lytwyn A, Lohfeld L, Redwood-Campbell L, Fowler N, Karwalajtys T. Barriers to acceptance of self-sampling for human papillomavirus across ethnolinguistic groups of women. Can J Public Health 2009;100:365-9.
21. Forrest S, McCaffery K, Waller J, Desai M, Szarewski A, Cadman L, et al. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and White British women in Manchester, UK. J Med Screen 2004;11:85-8.
22. Berner A, Hassel SB, Tebeu P, Untiet S, Kengne-Fosso G, Navarria I, et al. Human papillomavirus self-sampling in Cameroon: women's uncertainties over the reliability of the method are barriers to acceptance. J Low Genit Tract Dis 2013;17:235-41.
23. Mitchell S, Ogilvie G, Steinberg M, Sekikubo M, Biryabarema C, Money D. Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda. Int J Gynaecol Obstet 2011;114:111-5.
24. Sanchaisuriya P, Pengsaa P, Sriamporn S, Schelp FP, Kritpetcharat O, Suwanrungruang K, et al. Experience with a self-administered device for cervical cancer screening by Thai women with different educational backgrounds. Asian Pac J Cancer Prev 2004;5:144-50.
25. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health 2005;14:721-8.
26. Dzuba IG, Diaz EY, Allen B, Leonard YF, Lazcano Ponce EC, Shah KV, et al. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002; 11:265-75.
27. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002;55:435-9.
28. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 2006; 13:208-13.
29. Wikstrom I, Stenvall H, Wilander E. Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening. Acta Obstet Gynecol Scand 2007;86:720-5.
30. Bosgraaf RP, Ketelaars PJW, Verhoef VMJ, Massuger LFaG, Meijer CJLM, Melchers WJG, et al. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med 2014;64:108-13.
31. Bosgraaf RP, Verhoef VMJ, Massuger LFAG, Siebers AG, Bulten J, de Kuyper-de Ridder GM, et al. Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening. Int J Cancer 2014. http://dx.doi.org/10.1002/ijc.29026.
32. Virtanen A, Anttila A, Luostarinen T, Malila N, Nieminen P. Improving cervical cancer screening attendance in Finland. Int J Cancer 2014. http://dx.doi.org/10.1002/ijc.29176.
33. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
34. Finnish Cancer Registry, Statistics. Available online: www.cancerregistry.fi/statistics.
35. Terveyden ja hyvinvoinnin laitoksen asettaman papilloomavirustautien torjuntatyöryhmän selvitys 30.4.2011. National Institute for Health and welfare; 2011.
36. Varis T, Virtanen S. Tobacco statistics 2012. Official Statistic of Finland, vol. 30. National Institute for Health and welfare; 2013.